Search Within

Alexander Meyer Lesokhin

Formats
  1. Meeting Abstract (251)
  2. Journal Article (99)
  3. Research Letter (11)
  4. Review (7)
  5. Correspondence (3)
  6. Book Section (2)
  7. Editorial (2)
Groups
  1. Center for Hematologic Malignancies (375)
  2. Department of Medicine (375)
  3. Hematologic Malignancies Research (375)
  4. Hematologic Malignancies, Division of (375)
  5. Myeloma (375)
  6. Survivorship Research (221)

More Groups

People
  1. Hani Hassoun (199)
  2. Heather Landau (184)
  3. Sergio Giralt (182)
  4. David Chung (174)
  5. Neha Korde (170)
  6. Sham Mailankody (167)

More People

Years
  1. 2025 (6)
  2. 2024 (52)
  3. 2023 (77)
  4. 2022 (51)
  5. 2021 (31)
  6. 2020 (18)

More Years

Publications
  1. Blood (140)
  2. Clinical Lymphoma, Myeloma and Leukemia (57)
  3. Journal of Clinical Oncology (40)
  4. Biology of Blood and Marrow Transplantation (13)
  5. Leukemia and Lymphoma (13)
  6. Blood Advances (11)

More Publications

Publishers
  1. American Society of Hematology (151)
  2. Elsevier Inc. (78)
  3. American Society of Clinical Oncology (40)
  4. Nature Publishing Group (24)
  5. American Association for Cancer Research (14)
  6. Taylor & Francis Group (13)

More Publishers

Results (375)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • T-cell depleted allogeneic hematopoietic stem cell transplantation for patients with relapsed, high-risk multiple myeloma permits long-lasting remissions in the absence of graft-versus-host disease
    Meeting Abstract

    Koehne, G.; Devlin, S.; Landau, H.; Hassoun, H.; Lesokhin, A.; Lendvai, N.; Chung, D.; Giralt, S.
    Bone Marrow Transplantation (2015)

    Fulltext@MSK | Save
  • On being less tolerant: Enhanced cancer immunosurveillance enabled by targeting checkpoints and agonists of T cell activation
    Journal Article

    Lesokhin, A. M.; Callahan, M. K.; Postow, M. A.; Wolchok, J. D.
    Science Translational Medicine (2015)

    Fulltext@MSK | Save
  • Gain of chromosome 1q portends worse prognosis in multiple myeloma patients treated with novel agent based induction regimens even after autologous transplantation
    Meeting Abstract

    Shah, G. L.; Landry, C.; Londono, D.; Devlin, S.; Kosuri, S.; Lesokhin, A. M.; Lendvai, N.; Hassoun, H.; Chung, D. J.; Koehne, G.; more...
    Biology of Blood and Marrow Transplantation (2015)

    Fulltext@MSK | Save
  • Therapy-related B-lymphoblastic leukemia evolving during lenalidomide maintenance for multiple myeloma
    Meeting Abstract

    Sae-Ow, W.; Roshal, M.; Landau, H.; Lesokhin, A.; Pichardo, J.; Park, J.; Landgren, C. O.; Maslak, P.; Dogan, A.
    Laboratory Investigation (2015)

    Fulltext@MSK | Save
  • Therapy-related B-lymphoblastic leukemia evolving during lenalidomide maintenance for multiple myeloma
    Meeting Abstract

    Sae-Ow, W.; Roshal, M.; Landau, H.; Lesokhin, A.; Pichardo, J.; Park, J.; Landgren, C. O.; Maslak, P.; Dogan, A.
    Modern Pathology (2015)

    Fulltext@MSK | Save
  • PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma
    Journal Article

    Ansell, S. M.; Lesokhin, A. M.; Borrello, I.; Halwani, A.; Scott, E. C.; Gutierrez, M.; Schuster, S. J.; Millenson, M. M.; Cattry, D.; Freeman, G. J.; more...
    New England Journal of Medicine (2015)

    Fulltext@MSK | Save
  • Survival, response duration, and activity by BRAF mutation (MT) status of nivolumab (NIVO, anti-PD-1, BMS-936558, ONO-4538) and ipilimumab (IPI) concurrent therapy in advanced melanoma (MEL)
    Meeting Abstract

    Sznol, M.; Kluger, H. M.; Callahan, M. K.; Postow, M. A.; Gordon, R. A.; Segal, N. H.; Rizvi, N. A.; Lesokhin, A. M.; Atkins, M. B.; Kirkwood, J. M.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Interim analysis of a randomized phase II trial comparing continuous lenalidomide and dexamethasone to autologous stem cell transplantation in multiple myeloma patients responsive to lenalidomide and dexamethasone induction
    Meeting Abstract

    Weltz, J. I.; Landau, H.; Lendvai, N.; Chung, D. J.; Lesokhin, A. M.; Devlin, S. M.; Riedel, E.; Woo, K. M.; Stellman, A.; Chimento, D.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Efficacy and risk factors analysis of upfront autologous stem cell mobilization using plerixafor and granulocyte-colony stimulating factor (GCSF) in patients with multiple myeloma
    Meeting Abstract

    Ogunniyi, A.; Rodriguez, M.; Devlin, S. M.; Adel, N. G.; Landau, H.; Chung, D. J.; Lendvai, N.; Lesokhin, A. M.; Landgren, O.; Giralt, S. A.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Preliminary results of a phase I study of nivolumab (BMS-936558) in patients with relapsed or refractory lymphoid malignancies
    Meeting Abstract

    Lesokhin, A. M.; Ansell, S. M.; Armand, P.; Scott, E. C.; Halwani, A.; Gutierrez, M.; Millenson, M. M.; Cohen, A. D.; Schuster, S. J.; Lebovic, D.; more...
    Blood (2014)

    Fulltext@MSK | Save